These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 11429323)

  • 1. Human-SCID mouse chimeric models for the evaluation of anti-cancer therapies.
    Bankert RB; Egilmez NK; Hess SD
    Trends Immunol; 2001 Jul; 22(7):386-93. PubMed ID: 11429323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SCID mouse models to study human cancer pathogenesis and approaches to therapy: potential, limitations, and future directions.
    Bankert RB; Hess SD; Egilmez NK
    Front Biosci; 2002 Apr; 7():c44-62. PubMed ID: 11915860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The study of human neoplastic disease in severe combined immunodeficient mice.
    Williams SS; Alosco TR; Croy BA; Bankert RB
    Lab Anim Sci; 1993 Apr; 43(2):139-46. PubMed ID: 8320961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lupus manifestations in severe combined immunodeficient (SCID) mice and in human/mouse radiation chimeras.
    Sthoeger Z; Zinger H; Dekel B; Arditi F; Reisner Y; Mozes E
    J Clin Immunol; 2003 Mar; 23(2):91-9. PubMed ID: 12757261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Propagation of Human Hepatocytes in uPA/SCID Mice: Producing Chimeric Mice with Humanized Liver.
    Ohshita H; Tateno C
    Methods Mol Biol; 2017; 1506():91-100. PubMed ID: 27830547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The development of a novel immunotherapy model of human ovarian cancer in human PBL-severe combined immunodeficient (SCID) mice.
    Walker W; Gallagher G
    Clin Exp Immunol; 1995 Sep; 101(3):494-501. PubMed ID: 7664496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe combined immunodeficient mice engrafted with human splenocytes have functional human T cells and reject human allografts.
    Alegre ML; Peterson LJ; Jeyarajah DR; Weiser M; Bluestone JA; Thistlethwaite JR
    J Immunol; 1994 Sep; 153(6):2738-49. PubMed ID: 8077678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Xenogeneic PBL-scid mice: their potential and current limitations.
    Greenwood JD
    Lab Anim Sci; 1993 Apr; 43(2):151-5. PubMed ID: 8320963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-12 delivered by biodegradable microspheres promotes the antitumor activity of human peripheral blood lymphocytes in a human head and neck tumor xenograft/SCID mouse model.
    Kuriakose MA; Chen FA; Egilmez NK; Jong YS; Mathiowitz E; DeLacure MD; Hicks WL; Loree TL; Bankert RB
    Head Neck; 2000 Jan; 22(1):57-63. PubMed ID: 10585606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blocking antibodies induced by allergen-specific immunotherapy ameliorate allergic airway disease in a human/mouse chimeric model.
    Vizzardelli C; Gindl M; Roos S; Möbs C; Nagl B; Zimmann F; Sexl V; Kenner L; Neunkirchner A; Zlabinger GJ; Pickl WF; Pfützner W; Bohle B
    Allergy; 2018 Apr; 73(4):851-861. PubMed ID: 29159964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current status review: the severe combined immunodeficient (SCID) mouse: xenogeneic-SCID chimeras in the investigation of human autoimmune disease.
    Taylor PC
    Int J Exp Pathol; 1992 Apr; 73(2):251-9. PubMed ID: 1571284
    [No Abstract]   [Full Text] [Related]  

  • 12. Mice with Chimeric Human Livers and Their Applications.
    Douglas DN; Kneteman NM
    Methods Mol Biol; 2019; 1911():459-479. PubMed ID: 30593646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The SCID-hu mouse: an in vivo model for HIV-1 infection in humans.
    Bonyhadi ML; Kaneshima H
    Mol Med Today; 1997 Jun; 3(6):246-53. PubMed ID: 9211415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The severe combined immunodeficient (SCID) mouse as a model for the study of autoimmune diseases.
    Vladutiu AO
    Clin Exp Immunol; 1993 Jul; 93(1):1-8. PubMed ID: 8324894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting tissue factor on tumor vascular endothelial cells and tumor cells for immunotherapy in mouse models of prostatic cancer.
    Hu Z; Garen A
    Proc Natl Acad Sci U S A; 2001 Oct; 98(21):12180-5. PubMed ID: 11593034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engraftment of tonsillar mononuclear cells in human skin/SCID mouse chimera--validation of a novel xenogeneic transplantation model for autoimmune diseases.
    Yamanaka N; Yamamoto Y; Kuki K
    Microbiol Immunol; 2001; 45(7):507-14. PubMed ID: 11529556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human hepatic stem cells transplanted into a fulminant hepatic failure Alb-TRECK/SCID mouse model exhibit liver reconstitution and drug metabolism capabilities.
    Zhang RR; Zheng YW; Li B; Tsuchida T; Ueno Y; Nie YZ; Taniguchi H
    Stem Cell Res Ther; 2015 Mar; 6(1):49. PubMed ID: 25889844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinically relevant oral cancer model for serum proteomic eavesdropping on the tumour microenvironment.
    Balys R; Alaoui-Jamali M; Hier M; Black M; Domanowski G; Rochon L; Jie S
    J Otolaryngol; 2006 Jun; 35(3):157-66. PubMed ID: 16929991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling Tumor Immunology and Immunotherapy in Mice.
    Buqué A; Galluzzi L
    Trends Cancer; 2018 Sep; 4(9):599-601. PubMed ID: 30149876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunodeficient mouse models of lymphoid tumors.
    Imada K
    Int J Hematol; 2003 May; 77(4):336-41. PubMed ID: 12774920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.